Cefazolin

DrugBank ID: DB01327

Summary

Metric	Value
Total Predictions	56
KG+DL (Dual Validated)	2
DL Only	48
KG Only	6

Predictions

Indication	Score	Source
bacterial arthritis	0.9989	KG+DL
infectious otitis media	0.9944	DL
bronchitis	0.9931	DL
middle ear disease	0.9913	DL
chronic otitis media	0.9913	DL
suppurative otitis media	0.9913	DL
otosalpingitis	0.9909	DL
sclerosing cholangitis	0.9906	KG+DL
non-suppurative otitis media	0.9904	DL
allergic otitis media	0.9900	DL
middle ear cholesterol granuloma	0.9892	DL
urinary tract infection (disease)	0.9891	DL
Ureaplasma urethritis	0.9875	DL
gonococcal urethritis	0.9875	DL
pneumonia	0.9871	DL
meningococcal infection	0.9863	DL
uterine inflammatory disease	0.9824	DL
xanthogranulomatous pyelonephritis	0.9822	DL
bacterial pneumonia	0.9774	DL
infectious otitis interna	0.9762	DL
staphylococcus aureus infection	0.9737	DL
geniculate herpes zoster	0.9620	DL
hyperamylasemia	0.9599	DL
polyclonal hyperviscosity syndrome	0.9599	DL
congenital analbuminemia	0.9579	DL
streptococcal meningitis	0.9508	DL
blood group incompatibility	0.9431	DL
streptococcal pneumonia	0.9391	DL
premalignant hematological system disease	0.9343	DL
conjunctivitis	0.9336	DL
Lyme disease	0.9317	DL
ulcerative proctosigmoiditis	0.9311	DL
monoclonal gammopathy	0.9284	DL
postinfectious vasculitis	0.9282	DL
post-bacterial disorder	0.9280	DL
urogenital tuberculosis	0.9269	DL
post-infectious syndrome	0.9263	DL
hematological disease associated with an acquired peripheral neuropathy	0.9256	DL
paratyphoid fever	0.9251	DL
infective urethral stricture	0.9242	DL
chronic rhinosinusitis	0.9242	DL
epiglottitis	0.9223	DL
staphylococcal toxemia	0.9221	DL
chronic ethmoidal sinusitis	0.9216	DL
Chagas cardiomyopathy	0.9191	DL
infection-related hemolytic uremic syndrome	0.9182	DL
sinusitis	0.9178	DL
laryngotracheitis	0.9133	DL
punctate epithelial keratoconjunctivitis	0.9127	DL
pyelitis	0.9125	DL

Showing top 50 of 56 predictions.

External Links

Disclaimer
Predictions are for research purposes only and do not constitute medical advice.